[HTML][HTML] Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models to disease mechanisms
S Guo - The Journal of endocrinology, 2014 - ncbi.nlm.nih.gov
Insulin resistance is a major underlying mechanism for the “metabolic syndrome”, which is
also known as insulin resistance syndrome. Metabolic syndrome is increasing at an …
also known as insulin resistance syndrome. Metabolic syndrome is increasing at an …
Sp1 and the 'hallmarks of cancer'
K Beishline, J Azizkhan‐Clifford - The FEBS journal, 2015 - Wiley Online Library
For many years, transcription factor Sp1 was viewed as a basal transcription factor and
relegated to a role in the regulation of so‐called housekeeping genes. Identification of Sp1's …
relegated to a role in the regulation of so‐called housekeeping genes. Identification of Sp1's …
[HTML][HTML] Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia
Acute myeloid leukemia (AML) is a malignant tumor of the immature myeloid hematopoietic
cells in the bone marrow (BM). It is a highly heterogeneous disease, with rising morbidity …
cells in the bone marrow (BM). It is a highly heterogeneous disease, with rising morbidity …
Quantum dots as a platform for nanoparticle drug delivery vehicle design
CE Probst, P Zrazhevskiy, V Bagalkot, X Gao - Advanced drug delivery …, 2013 - Elsevier
Nanoparticle-based drug delivery (NDD) has emerged as a promising approach to
improving upon the efficacy of existing drugs and enabling the development of new …
improving upon the efficacy of existing drugs and enabling the development of new …
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and …
Aberrant DNA hypermethylation contributes to myeloid leukemogenesis by silencing
structurally normal genes involved in hematopoiesis. MicroRNAs (miRNAs) are noncoding …
structurally normal genes involved in hematopoiesis. MicroRNAs (miRNAs) are noncoding …
miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression
H Tang, M Deng, Y Tang, X Xie, J Guo, Y Kong… - Clinical Cancer …, 2013 - AACR
Purpose: The purpose of this study was to investigate the clinicopathologic significance and
potential role of miR-200b and miR-200c in the development and progression of gastric …
potential role of miR-200b and miR-200c in the development and progression of gastric …
[PDF][PDF] Sp1/NFκB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia
The biologic and clinical significance of KIT overexpression that associates with KIT gain-of-
function mutations occurring in subsets of acute myeloid leukemia (AML)(ie, core binding …
function mutations occurring in subsets of acute myeloid leukemia (AML)(ie, core binding …
Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia
X Huang, S Schwind, B Yu, R Santhanam, H Wang… - Clinical Cancer …, 2013 - AACR
Purpose: miR-29b directly or indirectly targets genes involved in acute myeloid leukemia
(AML), namely, DNMT s, CDK6, SP1, KIT, and FLT3. Higher miR-29b pretreatment …
(AML), namely, DNMT s, CDK6, SP1, KIT, and FLT3. Higher miR-29b pretreatment …
Epigenetic modifications of histones in periodontal disease
MD Martins, Y Jiao, L Larsson… - Journal of dental …, 2016 - journals.sagepub.com
Periodontitis is a chronic infectious disease driven by dysbiosis, an imbalance between
commensal bacteria and the host organism. Periodontitis is a leading cause of tooth loss in …
commensal bacteria and the host organism. Periodontitis is a leading cause of tooth loss in …
Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia
EK Ritchie, EJ Feldman, PJ Christos… - Leukemia & …, 2013 - Taylor & Francis
Abstract Treatment options for older patients with acute myeloid leukemia (AML) and for
patients with relapsed/refractory AML are limited, and outcomes are poor. Decitabine, a …
patients with relapsed/refractory AML are limited, and outcomes are poor. Decitabine, a …